{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:11:09Z","timestamp":1790428269235,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900522"],"award-info":[{"award-number":["31900522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120210588"],"award-info":[{"award-number":["22120210588"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2021SYPDRC036"],"award-info":[{"award-number":["2021SYPDRC036"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.tranon.2025.102380","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T02:31:15Z","timestamp":1745029875000},"page":"102380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells"],"prefix":"10.1016","volume":"56","author":[{"given":"Xiaojie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2614-1426","authenticated-orcid":false,"given":"Zhongping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102380_bib0001","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2025.102380_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2025.102380_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2025.102380_bib0004","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 6","key":"10.1016\/j.tranon.2025.102380_bib0005","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Ledermann","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tranon.2025.102380_bib0006","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy157","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Ledermann","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tranon.2025.102380_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-019-0484-6","article-title":"Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status","volume":"12","author":"Gadducci","year":"2019","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.tranon.2025.102380_bib0008","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-021-00331-9","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.tranon.2025.102380_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1111061","article-title":"Efficacy and safety of PD-1\/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: a systematic review and a meta-analysis","volume":"14","author":"Zeng","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.tranon.2025.102380_bib0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.annonc.2020.06.004","article-title":"The forefront of ovarian cancer therapy: update on PARP inhibitors","volume":"31","author":"Mirza","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tranon.2025.102380_bib0011","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/jc.2007-2404","article-title":"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine","volume":"93","author":"Zhang","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.tranon.2025.102380_bib0012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phymed.2018.09.212","article-title":"Efficacy and safety of berberine for dyslipidaemias: a systematic review and meta-analysis of randomized clinical trials","volume":"50","author":"Ju","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tranon.2025.102380_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118910","article-title":"A berberine hydrochloride-carboxymethyl chitosan hydrogel protects against Staphylococcus aureus infection in a rat mastitis model","volume":"278","author":"Tong","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.tranon.2025.102380_bib0014","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1021\/acsnano.9b01346","article-title":"Natural berberine-based Chinese herb medicine assembled nanostructures with modified antibacterial application","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.tranon.2025.102380_bib0015","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1002\/jmv.26747","article-title":"Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response","volume":"93","author":"Dai","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.tranon.2025.102380_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2468-1253(19)30409-1","article-title":"Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.tranon.2025.102380_bib0017","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/mc.22179","article-title":"Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice","volume":"54","author":"Li","year":"2015","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.tranon.2025.102380_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.775418","article-title":"Berberine suppresses stemness and tumorigenicity of colorectal cancer stem-like cells by inhibiting m(6)A methylation","volume":"11","author":"Zhao","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.tranon.2025.102380_bib0019","first-page":"13","article-title":"Delivery capacity and anticancer ability of the berberine-loaded gold nanoparticles to promote the apoptosis effect in breast cancer","author":"Chiu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2025.102380_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biopha.2017.05.069","article-title":"Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats","volume":"92","author":"Karnam","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.tranon.2025.102380_bib0021","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/1440-1681.13582","article-title":"Berberine inhibits non-small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis","volume":"49","author":"Ni","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.tranon.2025.102380_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108965","article-title":"Berberine regulates PADI4-related macrophage function to prevent lung cancer","volume":"110","author":"Gu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.tranon.2025.102380_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110245","article-title":"Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK\/mTOR\/p70S6K and Akt signaling pathways","volume":"128","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.tranon.2025.102380_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173887","article-title":"Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1","volume":"895","author":"Zhao","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.tranon.2025.102380_bib0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/tox.23076","article-title":"Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells","volume":"36","author":"Chuang","year":"2021","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.tranon.2025.102380_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.471","article-title":"Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition","volume":"8","author":"Hou","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.tranon.2025.102380_bib0027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40659-019-0243-6","article-title":"Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells","volume":"52","author":"Liu","year":"2019","journal-title":"Biol Res"},{"key":"10.1016\/j.tranon.2025.102380_bib0028","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/nprot.2016.095","article-title":"Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown","volume":"11","author":"Pertea","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.tranon.2025.102380_bib0029","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tranon.2025.102380_bib0030","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tranon.2025.102380_bib0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.tranon.2025.102380_bib0032","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tranon.2025.102380_bib0033","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.tranon.2025.102380_bib0034","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tranon.2025.102380_bib0035","article-title":"Inference of immune cell composition on the expression profiles of mouse tissue","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.tranon.2025.102380_bib0036","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7150\/ijms.9982","article-title":"Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance","volume":"12","author":"Liu","year":"2015","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.tranon.2025.102380_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.102174","article-title":"Effect of berberine nanoemulsion photodynamic therapy on cervical carcinoma cell line","volume":"33","author":"Floriano","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.tranon.2025.102380_bib0038","first-page":"24","article-title":"Berberine induces combined cell death in gastrointestinal cell lines","author":"Mori","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tranon.2025.102380_bib0039","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fcell.2020.00758","article-title":"Tumor microenvironment in ovarian cancer: function and therapeutic strategy","volume":"8","author":"Yang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.tranon.2025.102380_bib0040","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment","volume":"38","author":"Motohara","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2025.102380_bib0041","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis","volume":"37","author":"Ladanyi","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2025.102380_bib0042","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence","volume":"128","author":"Herranz","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tranon.2025.102380_bib0043","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.tranon.2025.102380_bib0044","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.tranon.2025.102380_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.tranon.2025.102380_bib0046","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.tranon.2025.102380_bib0047","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.tranon.2025.102380_bib0048","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s43018-023-00513-2","article-title":"A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-\u03bab signaling","volume":"4","author":"Altea-Manzano","year":"2023","journal-title":"Nat Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.tranon.2025.102380_bib0049","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1093\/annonc\/mdw084","article-title":"Opportunities in immunotherapy of ovarian cancer","volume":"27","author":"Coukos","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tranon.2025.102380_bib0050","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1002\/cam4.5590","article-title":"Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.tranon.2025.102380_bib0051","first-page":"13","article-title":"High density of CD16+ tumor-infiltrating immune cells in recurrent ovarian cancer is associated with enhanced responsiveness to chemotherapy and prolonged overall survival","author":"Lalos","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2025.102380_bib0052","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2018.07.025","article-title":"Patient inflammatory status and CD4+\/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer","volume":"151","author":"Pinto","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tranon.2025.102380_bib0053","article-title":"Efficacy evaluation of multi-immunotherapy in ovarian cancer: from bench to bed","volume":"13","author":"Hu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.tranon.2025.102380_bib0054","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41467-018-03301-0","article-title":"Sensitive and frequent identification of high avidity neo-epitope specific CD8 (+) T cells in immunotherapy-naive ovarian cancer","volume":"9","author":"Bobisse","year":"2018","journal-title":"Nat Commun"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T22:32:25Z","timestamp":1746829945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"alternative-id":["S1936523325001111"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102380","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102380"}}